Candida glabrata: An important fungal pathogen for the 21st century

Clinical Microbiology Newsletter

Volumn 23, Issue 22, 2001, Pages 171-176

  Fidel Jr , Paul L ^a   Vazquez, Jose A ^b   Sobel, Jack D ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA GLABRATA; FUNGUS IDENTIFICATION; GEL ELECTROPHORESIS; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MORPHOLOGY; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; VIRULENCE;

EID: 0035890147     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(01)80058-1     Document Type: Article

References (59)

1. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans
2. Candidiasis (moniliasis, thrush, Candida paronychia, Candida endocarditis, bronchomycosis, mycotic vulvovaginitis, candidosis)
3. Auxotrophic variants of Torulopsis glabrata
4. Clamped homogenous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections
5. Nosocomial Candida glabrata colonization: An epidemiologic study
6. Typing of Candida glabrata in clinical isolates by comparative sequence analysis of the cytochrome c oxidase subunit 2 gene distinguishes two clusters of strains associated with geographical sequence polymorphisms
7. Epidemiology of candidemia
8. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis
9. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients
10. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status
11. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe
12. Chronic mucocutaneous candidosis
13. Adherence and penetration of vascular endothelium by Candida yeasts
14. Candida glabrata displays pseudohyphal growth
15. In vitro proteinase production by Candida species
16. Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata
17. Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP
18. Growth inhibition of Candida by human oral epithelial cells
19. Penetration and damage of endothelial cells by Candida albicans
20. Immunological investigations in vaginal mycoses
21. Disseminated Candida glabrata: Report of a uniquely severe infection and a literature review
22. Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody
23. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus
24. A murine model of Candida glabrata vaginitis
25. Efficacy of D0870 treatment of experimental Candida vaginitis
26. Epidemiologica: Overview of resistance to oral antifungal agents in the immunocompromised host
27. Epidemiology of oral candidiasis in HIV infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
28. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
29. Overview of studies of fluconazole in oropharyngeal candidiasis
30. The growing problem of mycoses in patients infected with the human immunodeficiency virus
31. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
32. Chronic vulvovaginal candidiasis: Characteristics of women with Candida albicans, Candida glabrata, and no Candida
33. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care
34. Torulopsis glabrata vaginitis
35. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy
36. Weekly fluconazole for the treatment of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial
37. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection
38. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates
39. Torulopsis glabrata vaginitis: Clinical aspects and susceptibility to antifungal agents
40. Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy
41. Urinary candidiasis: A prospective study in hospitalized patients
42. Fungal infections of the genitourinary system
43. Candiduria: A randomized, double-blind study of treatment with fluconazole and placebo
44. Prospective multicenter surveillance study of funguria in hospitalized patients
45. Ecology and epidemiology of candidiasis
46. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
47. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
48. Management of invasive candidal infections: Result of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
49. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
50. Resistance of Candida species to fluconazole
51. Importance of Candida species other than C. albicans as pathogens in oncology patients
52. Amphotericin B: 30 years of clinical experience
53. Candida albicans: Biology, genetics, and pathogenicity
54. Mechanisms and clinical impact of antifungal resistance
55. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata
56. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata
57. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: Correlation of clinical response with in vitro susceptibility
58. Effects of voriconazole on Candida glabrata in vitro